肽菌素(饮水剂)对AA~+肉鸡生产性能和免疫性能的影响

1研究的目的与意义随着我国养殖业的迅速发展,由细菌或病毒所引起的动物疾病日渐增多,但抗生素的长期使用使动物产生了抗药性,药物残留也使畜产品的质量降低,影响人类的健康,同时也影响了畜产品的国际竞争力。因此开发新的无毒副作用的抗生素替代产品在近几年来备受关注。     

环境友好型农药剂型会议引关注

正本报讯近日,记者从中国农药工业协会了解到,由该协会从2008年开始举办,每隔两年组织召开的"环境友好型农药制剂加工技术及生产设备研讨会",对推动环境友好型农药剂型的发展起到了积极的促进作用,引起了行业内外相关企业的广泛关注。     

广东省饲用微生态制剂行业市场调研

微生态制剂又称益生素（益生菌），probifics，是从动物体内或者自然界分离、鉴定或通过生物工程人工重组的有益微生物，经培养、发酵、干燥、加工等特殊工艺制成的含有活菌的生物制剂或活菌制剂。     

微生态制剂在奶牛养殖中的研究进展

微生态制剂作为替代抗生素的潜在产品,在奶牛养殖中得到了广泛应用.微生态制剂通过调节菌群平衡以及代谢抗菌物质等促进奶牛的肠道健康,促进奶牛自身免疫系统的发育,在提高奶牛生长性能和抵御疫病中发挥着重要作用.微生态制剂在防治奶牛子宫内膜炎、奶牛乳房炎和犊牛腹泻等疾病中的效果显著.其次,微生态制剂还可以提高产奶量,改善乳品质.本文对奶牛养殖中微生态制剂使用的研究进展进行综述,对推广微生态制剂在奶牛养殖中的合理应用具有参考意义.     

喷施氨基酸硒叶面肥或SOD制剂对凌枣品质的影响

以12年生凌枣为试材,进行喷施氨基酸硒叶面肥或SOD制剂试验。结果表明,凌枣果实发育期喷施4次氨基酸硒叶面肥600倍液能显著提高凌枣果实硒含量,喷施SOD制剂1 000倍液对凌枣果实硒含量影响不大;喷施氨基酸硒叶面肥600倍液或SOD制剂1 000倍液均能显著提高凌枣果实SOD活性,对改善凌枣果实品质也有显著效果。     

三种微生态制剂对南方地区荷斯坦牛生产性能的影响

为研究微生态制剂对南方湿热气候下的荷斯坦牛生产性能的影响,选取胎次、泌乳天数、生理状况相近的荷斯坦牛600头,分为试验1组、试验2组与对照组,分别在日粮中添加美国某公司浓缩微生态产品、根源生物集团益倍健1801、美国某品牌微生态产品,进行对比饲喂试验。试验结果表明,益倍健1801对产奶量提高最明显,高出其余两组1kg以上,干物质采食量、消化吸收率与乳房炎发病率均优于其余两组。     

噬菌蛭弧菌、噬菌体和细菌素（四）

秦生巨老师1979年开始研究以“噬茵蛭弧菌、弧菌噬菌体为主的微生物生态制剂”。至今已经30多年，是我国噬菌蛭弧菌、弧菌噬菌体及其微生物生态制剂研究的创始人。     

中药抗体复合制剂防治仔猪腹泻试验

选择待开产未经大肠杆菌免疫来航蛋鸡150只,用ETEC K88+菌株C83907进行免疫后,收集高免蛋制备卵黄抗体粉。将中药提取物、卵黄抗体粉与载体按比例混合制成中药抗体复合制剂。分别选择3日龄和21日龄的杜×长×大三元杂交早期断奶仔猪18只和40只,人工感染C83907大肠杆菌后,口服含制备的中药抗体复合制剂进行被动免疫试验。结果表明:3日龄仔猪服用抗ETEC中药抗体复合制剂后,平均增重接近对照组(p>0.05),仔猪死亡率显著小于对照组(p<0.01)。21日龄服用中药抗体复合制剂组的仔猪增重高于卵黄抗体组(p<0.05)。研究结果表明,喂以6 g和10 g抗ETEC卵黄粉组的治愈率与抗生素治疗组差异不显著(p>0.05),比单一使用纯中药和卵黄抗体使用效果好(p<0.01)。     

Study on Liver-protective Effect of Chinese Herbal Compound Probiotics on Acute Liver Injury Layers

This experiment was conducted to investigate the liver-protective effect of Chinese herbal compound probiotics (CHCP) on acute liver injury layers.One hundred and eight 1 day old hens were divided into 4 groups with 3 replicates in each group and 9 layers per replicate in trial 1.The layers in model groups Ⅰ to Ⅲ were gavaged with 10% (V/V) soybean oil solution of carbon tetrachloride (SCCl₄) according to 1,2 and 4 mL/(kg·BW) at 14,28 and 35 d,respectively.The layers in control group were gavaged with 2 mL/(kg·BW) soybean oil.In trial 2,sixty 1 d layers were divided into 5 groups:Control group (soybean oil),model control group(SCCl₄)and low-dose,middle-dose and high-dose CHCP group (SCCl₄+1‰ CHCP,SCCl₄+2‰ CHCP and SCCl₄+4‰ CHCP respectively).CHCP were used by drinking water since 7 days.SCCl₄ were gavaged according to 2 mL/(kg·BW) at 14 and 28 d.The results showed as follows:The model of layers liver damage could be built by intragastric administration of 2 mL/(kg·BW) 10%(V/V) SCCl₄ at 14,28 d respectively,with the signs of hepatic steatosis,severe vacuolar degeneration,nuclear condensation and necrosis.Compared to the model control group,the serum AST levels in low,medium and high dose CHCP groups were decreased by 4.35% (P > 0.05),7.57% (P > 0.05) and 9.79% (P < 0.05),the serum ALT levels in medium and high dose CHCP groups were decreased by 34.92% (P < 0.01),36.51% (P < 0.01),the serum total bilirubin content in medium and high dose CHCP groups were decreased by 25.49% (P < 0.01),27.45% (P < 0.01).The liver cell congestion was reduced to varying degrees in different dose CHCP groups,and the liver cell had no vacuoles,arranged in neat rows,abundant cytoplasm and uniform in different dose CHCP groups.In conclusion,2‰,4‰ CHCP could reduce hepatocyte necrosis,decrease the serum activities of ALT,AST and total bilirubin levels,and had protective effect on hepatic injury induced by SCCl₄.